The House Energy & Commerce oversight subcommittee will hold a hearing on Sept. 30 to hear from scientists and public health experts on what criteria they think COVID-19 vaccines should be required to meet before being approved or authorized by FDA for distribution in the United States, the subcommittee announced Wednesday (Sept. 23). More information about the hearing, including a list of witnesses, will be made available closer to the hearing date, a press release from oversight subcommittee Chair Diana...